Silence Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,142 | $598 | $12,406 | $2,099 |
Gross Profit | -1,632 | -2,040 | 10,193 | 753 |
EBITDA | -21,441 | -17,139 | -4,035 | -14,908 |
EBIT | -21,556 | -17,258 | -4,155 | -15,029 |
Net Income | -27,012 | -15,562 | -1,876 | -14,412 |
Net Change In Cash | 1,142 | 598 | 12,406 | 2,099 |
Free Cash Flow | -19,705 | -4,881 | -7,495 | -11,867 |
Cash | 61,953 | 109,482 | 113,056 | 54,031 |
Basic Shares | 37,078 | 46,736 | 43,960 | 38,920 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $25,375 | $17,501 | $12,415 | $5,479 |
Gross Profit | 15,057 | 6,621 | 4,959 | 1,717 |
EBITDA | -49,778 | -47,885 | -45,421 | -35,529 |
EBIT | -50,276 | -48,367 | -45,848 | -36,025 |
Net Income | -43,267 | -40,489 | -39,410 | -32,547 |
Net Change In Cash | 25,375 | 17,501 | 12,415 | 5,479 |
Free Cash Flow | -39,395 | -45,896 | 5,472 | -11,290 |
Cash | 54,031 | 54,816 | 73,537 | 27,449 |
Basic Shares | 37,092 | 32,194 | 29,650 | 27,258 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.72 |
2024-06-30 | -$0.42 |
2024-03-31 | -$0.05 |
2023-12-31 | -$0.45 |
